ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,750.00
0.01%
S&P ASX All Technology
3,049.90
-0.57%
Brent Oil
82.87
0.59%
US Dollar vs AUD
1.51335
-0.11%
Bitcoin
63,080.98
2.66%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) News

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:STX
DateTimeSourceHeadlineSymbolCompany
11/05/202400:30RNS Regulatory NewsShield Therapeutics PLC Audited results for the year ended 31 Dec 2023LSE:STXShield Therapeutics Plc
01/05/202404:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:STXShield Therapeutics Plc
30/04/202416:00RNS Regulatory NewsShield Therapeutics PLC Business Update for Q1 2024LSE:STXShield Therapeutics Plc
16/04/202416:00RNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
21/02/202423:36Alliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
21/02/202418:00RNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
09/01/202422:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
09/01/202418:00UK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
08/12/202302:31Alliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
07/12/202318:00UK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
28/11/202304:24UK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
20/10/202321:45RNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
12/10/202321:14Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
12/10/202317:00UK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
04/10/202303:14Alliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
04/10/202301:00UK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
04/10/202300:29Alliance NewsAlliance NewsShield Therapeutics completes USD20 million SWK financingLSE:STXShield Therapeutics Plc
03/10/202317:00UK RegulatoryShield Therapeutics PLC Block listing Interim ReturnLSE:STXShield Therapeutics Plc
03/10/202317:00UK RegulatoryShield Therapeutics PLC Completion of SWK FinancingLSE:STXShield Therapeutics Plc
28/09/202323:54Alliance NewsAlliance NewsUPDATE: Shield Therapeutics completes GBP5 million share placingLSE:STXShield Therapeutics Plc
28/09/202321:50UK RegulatoryShield Therapeutics PLC Successful completion of US$6.1m Equity FundraiseLSE:STXShield Therapeutics Plc
28/09/202320:30Alliance NewsAlliance NewsShield Therapeutics raises funds for US sales push as loss narrowsLSE:STXShield Therapeutics Plc
28/09/202316:02UK RegulatoryShield Therapeutics PLC REX Retail OfferLSE:STXShield Therapeutics Plc
28/09/202316:01UK RegulatoryShield Therapeutics PLC $20m secured debt facility &proposed equity raiseLSE:STXShield Therapeutics Plc
28/09/202316:00UK RegulatoryShield Therapeutics PLC Interim results update and business updateLSE:STXShield Therapeutics Plc
07/09/202305:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsLSE:STXShield Therapeutics Plc
06/09/202316:00UK RegulatoryShield Therapeutics PLC Notice of Results and Change in reporting currencyLSE:STXShield Therapeutics Plc
07/08/202302:07Alliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:STXShield Therapeutics Plc
06/08/202323:17Alliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:STXShield Therapeutics Plc
24/07/202323:27UK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
 Showing the most relevant articles for your search:LSE:STX

Your Recent History

FTSE
UKX
FTSE 100
ASX
FMG
Fortescue
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
GOOGL
Alphabet
ASX
CSL
CSL
COIN
BTCUSD
Bitcoin
ASX
NCM
Newcrest Mining
ASX
TLS
Telstra
NASDAQ
AAPL
Apple
ASX
AMP
AMP
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
XFL
S&P ASX 50
ASX
CBA
Commonwealth Bank Of Aus...
ASX
WPL
Woodside Petroleum
ASX
XTO
S&P ASX 100
ASX
RIO
Rio Tinto
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved